Estrogen Receptor Expression Changes After Puberty in the Porcine Anterior Cruciate Ligament
Journal of Orthopaedic Research · 2026-11 · 44 (11)
DOI: 10.1002/jor.70301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 06.11.2026. Verfasst von Jacob D Thompson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lampe Joint Department of Biomedical Engineering, North Carolina State University and the University of North Carolina - Chapel Hill, Raleigh, North …. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament, Sexual Maturation, Receptors, Estrogen, Estrogen Receptor alpha. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, National Science Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Anterior cruciate ligament (ACL) injuries disproportionately affect female adolescent athletes, with hormonal influences implicated in this sex disparity. However, the relationship between pubertal hormonal changes and ACL gene and protein expression remains poorly understood. This study characterized hormone receptor expression and transcriptional profiles in the anteromedial (AM) and posterolateral (PL) bundles of female porcine ACLs before and after puberty. ACL bundles were collected from pre‐pubescent (8 weeks) and post‐pubescent (> 8 months) female Yorkshire cross‐breed pigs ( n = 6/group) and analyzed using gene expression profiling, western blotting, and immunofluorescence. Pre‐pubescent ACLs exhibited greater expression of primary matrix genes (COL1A1, COL1A2, ELN, TNMD), suggesting active matrix synthesis, while post‐pubescent ACLs showed elevated secondary matrix genes (COL3A1, LUM, COMP), indicating a homeostatic state. Notably, estrogen receptor alpha (ERα) gene and protein expression were significantly greater in post‐pubescent ACLs, particularly in AM bundles, whereas G protein‐coupled estrogen receptor (GPR30) expression was elevated pre‐puberty. Both receptors were distributed homogeneously throughout the tissue. Histologically, post‐pubescent ACLs demonstrated decreased cellularity and thicker fascicles compared to pre‐pubescent tissues. These findings indicate that ACL sensitivity to estrogen varies across development, with increased ERα expression post‐puberty potentially rendering the ligament more responsive to circulating estrogen. This work provides foundational evidence for age‐dependent hormonal responsiveness in the ACL and motivates further investigation into how sex hormones influence ACL injury risk in adolescent females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lampe Joint Department of Biomedical Engineering, North Carolina State University and the University of North Carolina - Chapel Hill, Raleigh, North Carolina, USA.
- Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Orthopaedics, University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Jacob D Thompson, Matthew B Fisher
Förderung
- NIAMS NIH HHS
- National Science Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Thompson, J. D., Easson, M. E., & Fisher, M. B. (2026). Estrogen Receptor Expression Changes After Puberty in the Porcine Anterior Cruciate Ligament. Journal of Orthopaedic Research, 44(11). https://doi.org/10.1002/jor.70301
Vancouver
Thompson JD, Easson ME, Fisher MB. Estrogen Receptor Expression Changes After Puberty in the Porcine Anterior Cruciate Ligament. Journal of Orthopaedic Research. 2026;44(11). doi:10.1002/jor.70301
BibTeX
@article{Thompson2026,
author = {Thompson, Jacob D and Easson, Margaret E and Fisher, Matthew B},
title = {Estrogen Receptor Expression Changes After Puberty in the Porcine Anterior Cruciate Ligament},
journal = {Journal of Orthopaedic Research},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/jor.70301}
}
EUVIMED